INTRODUCTION
============

Sphingolipids are ubiquitous structural components of eukaryotic cell membranes, and their bioactive metabolites (sphingosine, sphingosine-1-phosphate, ceramide, ceramide-1 phosphate and lyso-sphingomyelin) are known to act as second messengers in the regulation of signaling pathways [@B1][@B2][@B3][@B4][@B5][@B6]. Sphingosine (and related sphingoid bases) and ceramide are involved in the regulation of actin cytoskeleton organization, endocytosis, degradation of nutrient permeases, apoptosis, cell senescence and cell cycle arrest whereas sphingosine-1-phosphate plays a key role in proliferation, mitogenesis, cell migration, cell survival and inflammation (in higher eukaryotes) [@B5]. Thus, subtle variations on the relative amounts of sphingosine-1-phosphate and sphingosine/ceramide are expected to determine cell fate in response to environmental or metabolic stresses. The importance of sphingolipids is recognized by the fact that sphingolipid signaling is implicated in the pathobiology of cancer and other human diseases such as diabetes, heart disease, microbial infections, neurological and immune dysfunctions [@B7][@B8][@B9][@B10][@B11].

Sphingolipids metabolism and their route of synthesis are highly conserved from yeast to mammalian cells. Studies using the budding yeast *Saccharomyces cerevisiae*have served in many ways to foster our understanding of sphingolipid dynamics and their role in the regulation of cell cycle, cell integrity, endocytosis, cytoskeleton dynamics and protein turnover [@B4][@B5]. Additionally, sphingolipids have been implicated in the regulation of stress responses and longevity. For instance, yeast mutants lacking Ydc1p (dihydroceramidase) are characterized by increased chronological lifespan (CLS) whereas the overexpression of *YDC1* triggers mitochondria and vacuolar fragmentation, apoptosis and accelerated aging in yeast [@B12]. Genes involved in sphingolipid metabolism (*LAG1*, *YPC1*, *YSR3*, *IPT1*, and *LCB5*) show variable expression in senescent and apoptotic cells [@B13]. More recently, it was shown that the downregulation of sphingolipid synthesis increases yeast CLS in part due to a reduction in long-chain bases (LCBs) mediated activation of Sch9p, the yeast homologue of mammalian ribosomal S6K protein kinase [@B14]. Furthermore, ceramide synthase (Lag1p) and LCB kinase (Lcb4p) activities decrease upon entry into the stationary phase, leading to a large increase in the levels of LCBs [@B15].

We have previously demonstrated that Isc1p, the yeast orthologue of mammalian neutral sphingomyelinase-2 (nSMase2) responsible for the hydrolysis of complex inositol phosphosphingolipids to produce ceramide, is implicated in oxidative stress resistance and CLS in yeast. Isc1p-deficient cells display shortened CLS, oxidative stress sensitivity and impaired redox and iron homeostasis [@B16]. Analogous to the role of ceramide and ceramide-activated protein phosphatases in regulating mammalian cell apoptosis, Isc1p acts upstream of Sit4p, the catalytic subunit of protein phosphatase related to type 2A protein phosphatases (PP2A) in yeast. Indeed, *SIT4*deletion restores mitochondrial function of *isc1*Δ cells, increasing oxidative stress resistance and extending CLS [@B17]. The activation of the HOG (High Osmolarity Glycerol) pathway is also deleterious for *isc1*Δ cells since ceramide signaling increases the phosphorylation of the Hog1p mitogen activated protein kinase (MAPK) and the disruption of*HOG1*attenuates the phenotypes of Isc1p-deficient cells [@B18].

Recent studies also link ceramide to other important signaling pathways involved in the regulation of cell growth and survival, namely the TOR (Target of Rapamycin) pathway. This pathway is highly conserved among organisms, ranging from flies, nematodes, protozoa alongside with mammals [@B19][@B20][@B21][@B22][@B23][@B24]. In *S. cerevisiae*, the TOR pathway is controlled by two Ser/Thr protein kinases, Tor1p and Tor2p, which assemble into two protein complexes with distinct subunit composition and regulatory roles [@B25][@B26][@B27]. The rapamycin-sensitive TOR complex 1 (TORC1) contains either Tor1p or Tor2p and is mostly associated with the regulation of cell growth (nutrient sensing), autophagy, ribosomal and protein turnover and cell proliferation [@B27][@B28]. The TOR complex 2 (TORC2) contains Tor2p, but not Tor1p, mediates the proper maintenance of the cell cytoskeleton [@B29] and regulates ceramide biosynthesis by an Ypk2p-dependent mechanism [@B30]. Furthermore, TORC2 indirectly modulates Isc1p turnover through the phosphorylation and activation of Slm1p and Slm2p [@B31].

The TORC1 pathway has also been linked to mitochondrial function and yeast CLS [@B32][@B33]. In fact, the deletion of *TOR1* or pharmacological inhibition of TORC1 with rapamycin extends CLS in yeast and other organisms [@B32][@B34][@B35]. TORC1 is active during early stages of growth and represses the induction of stress responses and entry into the stationary phase, in part by inhibiting the Rim15p protein kinase and consequently the translocation of Msn2p/4p and Gis1p transcription factors into the nucleus [@B36][@B37]. Reducing TORC1 signaling at early stages of growth extends CLS by an intrinsic mechanism involving enhanced mitochondrial membrane potential and superoxide production. This in turn induces an adaptive response that contributes to decrease ROS production in the stationary phase and promotes longevity in yeast [@B33]. Moreover, reduced TORC1 signaling derepresses Rim15p and triggers the expression of genes regulated by the mitochondrial signaling pathway known as the retrograde response [@B38][@B39][@B40] as well as stress-related genes under the control of Msn2p/Msn4p [@B37][@B41].

Some authors have identified downstream targets of TORC1 involved in the regulation of stress response and aging, namely the AGC protein kinase Sch9p and the Sit4p protein phosphatase. Apart from sensing nutrient and stress signals from TORC1, both proteins also regulate CLS by integrating sphingolipid signaling. In addition to phosphorylation in the C-terminus mediated by TORC1, Sch9p is phosphorylated in a Thr570 residue in the activation loop by Pkh1/2p protein kinases, homologues of mammalian phosphoinositide-dependent protein kinase 1 (PDK1), in response to LCBs [@B14][@B42]. On the other hand, Sit4p is downregulated by TORC1 in a Tip41p/Tap42p manner [@B43][@B44] but is also activated by ceramide and functions downstream of Isc1p [@B17]. How this complex network of interacting pathways regulates CLS remains poorly characterized.

In this study, we show that the activation of the TORC1-Sch9p pathway impairs oxidative stress resistance, mitochondrial function and CLS in *isc1*Δ cells. Consistent with TORC1 activation, the autophagic flux is decreased in *isc1*Δ cells. Our results suggest that Isc1p regulate mitochondrial function and yeast CLS through the TORC1-Sch9p but Isc1p and TORC1 also seem to act through independent pathways. The suppression of *isc1*( phenotypes by *TOR1*deletion is not associated with the attenuation of Hog1p hyperphosphorylation. Our data also support a model in which TORC1 downstream effectors Sit4p and Sch9p act as physiological hubs integrating nutrient and ceramide signaling driven by Isc1p.

RESULTS
=======

The deletion of *TOR1* or *SCH9* suppresses the shortened CLS and oxidative stress sensitivity of *isc1*Δ cells
---------------------------------------------------------------------------------------------------------------

To assess changes in TORC1 signaling associated with Isc1p deficiency, we have monitored TORC1 activity *in vivo* by assessing TORC1-dependent Sch9p phosphorylation at the C-terminus [@B45].

The results show that Sch9p is hyperphosphorylated in *isc1*Δ mutants when compared to parental cells, indicative of increased TORC1 activity (Fig. 1A-B). Apart from TORC1, Sch9p can also be phosphorylated by Pkh1/2p in response to LCBs. Since basal levels of phytosphingosine (PHS) are increased in *isc1*Δ cells during aging [@B17], we also assessed the Pkh1/2p-dependent phosphorylation of Sch9p on the Thr570 residue. The results show that the levels of Sch9p-phospho-Thr570 were similar in parental and *isc1*Δ cells (Supplementary Fig. S1).

![FIGURE 1: Isc1p-deficient cells exhibit enhanced TORC1 activity *in vivo.*\
The TORC1-dependent C-terminal phosphorylation of Sch9p was used to assess TORC1 activity *in vivo*.\
**(A)** *S. cerevisiae*BY4741 and *isc1*Δ cells transformed with pJU676 (expressing *SCH9-5HA*) were grown in SC-medium to the exponential phase and NTCB-treated protein extracts were analyzed by immunoblotting using anti-HA antibody, as described in *Materials and Methods*. A representative blot out of three is shown.\
**(B\>** Quantification of band intensities was performed by densitometry. The ratio between phosphorylated and unphosphorylated Sch9p (P~i~^+^/P~i~^-^) is shown. Values are mean ± SD of at least three independent experiments. \*\*\*\*p\<0.0001.](mic-01-021-g01){#Fig1}

This led us to postulate that TORC1 activation may contribute to *isc1*Δ phenotypes. To test this hypothesis, we then evaluated if the deletion of *TOR1*or *SCH9* could abolish the premature aging and hydrogen peroxide sensitivity of *isc1*Δ cells. In agreement with previous reports [@B16][@B17][@B18], *isc1*Δ cells presented a shortened CLS compared to parental cells (Fig. 2A). Although the acidification of the growth medium due to acetic acid production decreases yeast lifespan [@B46], it is unlikely that it contributes to the shortened CLS of *isc1*Δ cells since *ISC1* deletion increases acetic acid resistance [@B47]. As expected, *tor1*Δ and *sch9*Δ cells exhibited an increased lifespan (Fig. 2A). The effect of *SCH9*deletion was significantly lower to that reported by other groups [@B48]. This probably results from differences in the growth medium composition, in particular amino acid concentration. Indeed, *sch9*Δ mutants display increased lifespan when cells are grown in media supplemented with a 3.5-fold excess of amino acids but present shortened lifespan than parental cells when grown in media with 0.5-fold amino acid content [@B49]. Importantly, the deletion of *TOR1*or*SCH9*in *isc1*Δ cells significantly extended the CLS of this mutant but the *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ double mutants exhibited a shorter CLS compared to that of *tor1*Δ and *sch9*Δ cells, respectively (Fig. 2A).

![FIGURE 2: The deletion of *TOR1* and *SCH9* abolishes the shortened CLS, oxidative stress sensitivity and mitochondrial dysfunctions displayed by *isc1*Δ cells.\
**(A)** *S. cerevisiae* BY4741*, isc1*Δ, *tor*1Δ and *isc*1Δ*tor1*Δ, *sch9*Δ and *isc1*Δ*sch9*Δ cells were grown in SC-medium and kept in the medium at 26°C. The viability was determined by standard dilution plate counts and expressed as the percentage of the colony-forming units at time *T* in relation to T~0~. Values are mean ± SD of at least three independent experiments.\
**(B, C)**Yeast cells were grown in SC-medium to the exponential phase (B) or stationary phase (48 hours after exponential phase) (C) and exposed to 1.5 mM H~2~O~2~ for 60 min (B) or 300 mM H~2~O~2~ for 30 min (C). Cell viability was determined by standard dilution plate counts and expressed as the percentage of the colony-forming units (treated cells versus untreated cells). Values are mean ± SD of at least three independent experiments. \*\*\*\*p\<0.0001. \*\*\*p\<0.001.\
**(D)** *S. cerevisiae* BY4741,*isc1*Δ, *tor1*Δ and *isc1*Δ*tor1*Δ, *sch9*Δ and *isc1*Δ*sch9*Δ cells were grown in SC-medium to the exponential phase and then diluted to OD~600~=0.1. Fivefold dilution series were spotted on YPD (glucose) or YPG (glycerol) medium and cells were grown at 26°C for 4 days.\
**(E)**Oxygen consumption rate was measured in cells grown to PDS phase, as described in *Materials and Methods*. Values are mean ± SD of at least three independent experiments. \*\*\*\*p\<0.0001; \*p\<0.05.\
**(F)** Cytochrome *c*oxidase (COX) activity was determined in cells grown to the PDS phase. Cells were lysed and enzymatic activity was measured as described in *Materials and Methods*. Values are mean ± SD of at least three independent experiments. \*\*\*\*p\<0.0001; \*\*\*p\<0.001](mic-01-021-g02){#Fig2}

To assess oxidative stress resistance, cells were grown to the exponential or early stationary phase and treated with H~2~O~2~. Consistent with published data [@B50], *tor1*Δ and *sch9*Δ cells were more resistant to oxidative stress than parental cells (Fig. 2B-C). The deletion of *TOR1* or *SCH9* suppressed the hydrogen peroxide sensitivity of *isc1*Δ cells (Fig. 2B-C). Similar results were obtained by the pharmacological inhibition of TORC1 using rapamycin (Supplementary Fig. S2). These results implicate TORC1-Sch9p activation in the premature aging and oxidative stress sensitivity of Isc1p-deficient cells.

Reduced TORC1 signaling enhances mitochondrial coupled respiration in *isc1*Δ cells
-----------------------------------------------------------------------------------

It was previously shown that *tor1*Δ cells have an extended CLS in part associated with improved and better coupled mitochondrial respiration at early stages of growth, which ultimately preconditions yeast to better survive on the stationary phase [@B33]. Therefore, we evaluated if the deletion of *TOR1* and *SCH9* could improve mitochondrial fitness of *isc1*Δ cells, eventually contributing to CLS extension observed in *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ double mutants. To address this hypothesis, we analyzed cell growth in medium containing glycerol, a non-fermentable carbon source, as well as oxygen consumption and cytochrome *c* oxidase (COX) activity. It was observed that the growth defect of *isc1*Δ cells on glycerol medium was suppressed upon the deletion of *TOR1* or *SCH9* (Fig. 2D). As expected, the deletion of *ISC1* almost completely abolished oxygen consumption and COX activity in the post-diauxic shift (PDS; respiratory) phase (Fig. 2E-F). In *tor1*Δ and *sch9*Δ cells, both oxygen consumption and COX activity were increased when compared to parental cells. Notably, *TOR1 and SCH9*disruption suppressed the defects observed in *isc1*Δ cells: both oxygen consumption and COX activity increased in *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ cells, although to levels lower than those observed in *tor1*Δ and *sch9*Δ cells, respectively (Fig. 2E-F). To assess if enhanced mitochondrial respiration coupling contributes to the lifespan extension of *isc1*Δ cells imposed by reduced TORC1 signaling, CLS was analyzed in cells treated with 2,4-dinitrophenol (DNP), which decreases mitochondrial membrane potential and uncouples electron transport from ATP synthesis. Untreated Isc1p-deficient cells exhibited a shortened CLS that was not affected by exposure to DNP (Fig. 3), providing strong evidence that mitochondrial dysfunction largely contributes to *isc1*Δ phenotypes. In *tor1*Δ mutants, DNP significantly affected cell viability (e.g., it decreased 40% in DNP-treated vs control cells aged for 2 days). However, the detrimental effect of DNP in *tor1*Δ mutants was lower to the observed in parental cells (in this strain, the viability of cells treated with DNP and aged for 2 days decreased 68%). This is consistent with published data showing that *tor1*Δ cells present better coupled respiration when compared to parental cells [@B33], and therefore are able to mount a more effective adaptive response to counteract DNP effects. The deletion of *TOR1* in *isc1*Δ cells extended CLS (in cells untreated with DNP) and this effect appears to be correlated with an increased coupled respiration imparted by reduced TORC1 signaling since DNP treatment decreased cell viability in such conditions. The *isc1*Δ*tor1*Δ double mutant presented an intermediate phenotype between parental and *tor1*Δ cells since, at day 2 of aging, parental,*tor1*Δ and*isc1*Δ*tor1*Δ cells presented 32%, 60% and 40% cell viability, respectively. Taking together, we claim that improved mitochondrial fitness (increased coupled respiration) promoted by the deletion of *TOR1* *per se* extends CLS in *isc1*Δ cells.

![FIGURE 3: Increased mitochondrial coupled respiration imparted by reduced TORC1 signaling extends lifespan in *isc1*Δ cells.\
*S. cerevisiae*BY4741, *isc1*Δ*, tor1*Δ and *isc1*Δ*tor1*Δ cells were grown in SC-medium to the PDS phase, treated with 10 µM 2,4-dinitrophenol (DNP; filled squares) or vehicle (DMSO; empty circles) and kept in the medium at 26°C. The viability was determined by standard dilution plate counts and expressed as the percentage of the colony-forming units at time T in relation to T~0~. Values are mean ± SD of at least three independent experiments.](mic-01-021-g03){#Fig3}

Hyperpolarization and fragmentation of the mitochondrial network in *isc1*Δ cells are suppressed by *TOR1* or *SCH9* deletion
-----------------------------------------------------------------------------------------------------------------------------

To get further insights into alterations in mitochondrial function operating on *isc1*Δ cells, we assessed the mitochondrial membrane potential (Δψ~m~), a parameter that has been used to monitor changes on bioenergetics and functions as a key indicator of cell health or injury [@B51]. For this purpose, yeast cells were labeled with a mitochondria-specific voltage-dependent dye, 3,3-dihexyloxacarbocyanine iodide \[DiOC~6~(3)\], which aggregates and preferentially accumulates into functional mitochondria, and analyzed by flow cytometry (Fig. 4A). At the PDS phase, cells lacking Isc1p displayed an enhanced Δψ~m~ when compared to parental cells, which is consistent with mitochondrial hyperpolarization. In contrast, *tor1*Δ and *sch9*Δ cells had a slightly lower Δψ~m~, which has been associated with mild mitochondrial uncoupling [@B33]. Both *TOR1* and *SCH9*disruption in *isc1*Δ cells reversed the mitochondrial hyperpolarization and decreased the Δψ~m~ to values similar to those observed in the respective single mutants. This probably increases cell survival in *isc1*Δ*tor1*Δ and*isc1*Δ*sch9*Δ cells, since *isc1*Δ cells die by caspase-dependent apoptosis upon oxidative stress and during cell aging [@B16] and mitochondrial hyperpolarization has been associated with the activation of a mitochondrial dependent apoptotic pathway, which initially involves a transient hyperpolarization followed by depolarization of the mitochondrial membrane and release of cytochrome*c* from the mitochondria into the cytosol [@B52].

![FIGURE 4: The mitochondrial membrane hyperpolarization and decreased autophagic flux contribute to mitochondrial dysfunction and impairment of mitochondrial dynamics in *isc1*Δ cells.\
**(A)** *S. cerevisiae* BY4741, *isc1*Δ, *tor1*Δ and *isc1*Δ*tor1*Δ, *sch9*Δ and *isc1*Δ*sch9*Δ cells were grown in SC-medium to the PDS phase, stained with the potential-sensitive dye 3,3-dihexyloxacarbocyanine iodide \[DiOC~6~(3)\] for 30 min and analyzed by flow cytometry. Treatment of the parental strain (BY4741) with FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) was used as a positive control (depolarizing event). Values are mean ± SD of at least three independent experiments. \*\*\*\*p\<0.0001; \*\*\*p\<0.001; \*\*p\<0.01.\
**(B)** Yeast cells transformed with pYX222-mtDsRed were grown to the exponential and PDS phases and analyzed by fluorescence microscopy, as described in *Materials and Methods*. Live cells were visualized by fluorescence microscopy. A representative experiment out of three is shown. Scale bar: 5 µm.\
**(C)** *S. cerevisiae* BY4741, *isc1*Δ, *tor1*Δ and *isc1*Δ*tor1*Δ, *sch9*Δ and *isc1*Δ*sch9*Δ cells carrying pRS416 GFP-*ATG8* were grown to the exponential phase in SC-medium and treated with either rapamycin (200 ng/mL) or DMSO (vehicle) for 3 hours. Proteins were analyzed by immunoblotting, using anti-GFP antibody.\
**(D)** The autophagic flux was calculated by the ratio between the free GFP signal and the sum of free GFP and GFP-Atg8p signals. Values are mean ± SD of at least three independent experiments \*\*\*\*p\<0.0001; \*\*\*p\<0.001; \*\*p\<0.01.\
**(E)** *S. cerevisiae* BY4741 and *isc1*Δ cells carrying pRS416 GFP-*ATG8* were grown to PDS phase, washed twice with water and then maintained in water. Proteins were analyzed by immunoblotting, using anti-GFP antibody.](mic-01-021-g04){#Fig4}

The mitochondrial membrane potential plays a key role in the regulation of mitochondrial morphology and alterations on this parameter were demonstrated to impact on mitochondrial dynamics [@B53][@B54][@B55][@B56]. To assess changes in mitochondrial network dynamics, yeast cells expressing a mitochondria-targeted DsRed protein were analyzed by fluorescence microscopy. At the exponential phase, the mitochondrial network was not yet fully developed and no significant differences were observed between the parental and *isc1*Δ cells (Fig. 4B). This was expected since cells are undergoing fermentative growth at this phase. However, in the PDS phase, loss of Isc1p led to the formation of a typical punctuate pattern contrasting with the tubular and well-organized network observed in healthy parental cells (Fig. 4B). This structural alteration has been associated with mitochondrial fragmentation and observed in cells undergoing apoptotic cell death. The normal tubular mitochondrial network was restored upon disruption of *TOR1* or *SCH9*in *isc1*Δ cells (Fig. 4B), suggesting that TORC1 and its downstream target Sch9p are also implicated in the regulation of mitochondrial dynamics by promoting network fragmentation.

Previous studies have demonstrated that autophagy has an important role in maintaining proper mitochondrial function and dynamics since autophagy-defective mutants present severe mitochondria dysfunctions [@B57][@B58]. In particular, the regulation of the mitochondrial membrane potential appears to be crucial to regulate autophagic flux. In addition, accumulating evidence show that defects in autophagy deregulate mitochondrial dynamics [@B59]. Since *isc1*Δ cells present similar phenotypic features and TORC1, a negative regulator of autophagy, is activated in this mutant strain, we evaluated if these cells present autophagy defects. For this purpose, we have monitored the processing of GFP-Atg8p. Once autophagy is induced, GFP-Atg8p is recruited to drive autophagosome biogenesis and then delivered to the vacuole inside the autophagic body. Whereas Atg8p is degraded by resident vacuolar hydrolases, the GFP moiety is relatively resistant to proteolysis. Therefore, the appearance of free GFP signal is indicative of autophagy induction. To induce autophagy, yeast cells were treated with rapamycin. Under these conditions, the autophagic flux was significantly lower in Isc1p-deficient cells (35%) when compared to the parental strain (60%) (Fig. 4C-D). Notably, a slower migrating band (above free GFP) was observed in *isc1*Δ cells, both under basal conditions and upon rapamycin treatment (see Supplementary Fig. S3 for a longer exposure time of the Western blot). It probably results from an incomplete or aberrant processing of GFP-Atg8p, possibly due to vacuolar dysfunction (defective Pep4p-dependent proteolytic activity) [@B47] or alterations in vacuolar morphology upon deletion of *ISC1* [@B60]. In *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ double mutants, the autophagic flux increased to values close to those observed for the respective *tor1*Δ and *sch9*Δ single mutants (Fig. 4C-D). It should be noted that rapamycin is predicted to have still some effect on *tor1*Δ cells because there is yet some functional TORC1 signaling. In fact, TORC1 complex is sensitive to rapamycin due to binding of FKBP-rapamycin complex to subunits of TORC1. Thus, TORC1 is functional (although with reduced activity) in *tor1*Δ cells since it may also contain Tor2p (which may replace Tor1p) in its composition. These results implicate TORC1 and its downstream effector, Sch9p, in the deregulation of autophagy, possibly contributing to mitochondrial network fragmentation and impairment of oxidative stress resistance and CLS in *isc1*Δ cells.

To provide further evidence that autophagy is impaired in *isc1*Δ cells, we have also monitored the autophagic flux during chronological aging. The rate of viability loss during aging of this mutant is very high when cells are grown in SC-medium (Fig. 2A). Thus, to avoid unspecific changes that may occur due to cell death, we assessed autophagy under conditions of calorie restriction (cells grown to PDS phase, washed and maintained in water overtime). We have previously shown that calorie restriction increases CLS in both *isc1*Δ and parental cells, but *isc1*Δ mutants still exhibit a premature aging phenotype [@B17]. The results show that the autophagic flux increased in parental cells aged for 3-5 days, but it was significantly compromised in *isc1*Δ cells (Fig. 4E). Overall, the data suggests that autophagy is impaired in this mutant strain.

*TOR1* and *SCH9* deletion in *isc1*Δ cells decrease ROS levels, catalase A deficiency and apoptotic cell death
---------------------------------------------------------------------------------------------------------------

Apoptosis and aging has been extensively associated with enhanced ROS production [@B61][@B62][@B63][@B64]. Thus, the improvement of mitochondrial function and/or antioxidant defenses may decrease mitochondrial ROS production or increase its detoxification, leading to CLS extension. To test this hypothesis, ROS levels were measured by flow cytometry using early stationary phase cells stained with dihydroethidium (DHE), a molecular probe sensitive to superoxide radicals. The results show that ROS levels were low in parental, *tor1*Δ and *sch9*Δ cells but approximately 50% of *isc1*Δ cells were DHE-positive (Fig. 5A). In *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ mutants, ROS levels were higher than in parental cells but significantly lower when compared to Isc1p-deficient cells (by approximately one-half), suggesting that *TOR1* and *SCH9*deletion increase survival in *isc1*Δ cells by decreasing ROS generation.

![FIGURE 5: The deletion of *TOR1*or*SCH9*decreases ROS production, attenuates catalase A deficiency and diminishes apoptotic cell death in *isc1*Δ cells.\
**(A)***S. cerevisiae*BY4741, *isc1*Δ*, tor1*Δ and *isc1*Δ*tor1*Δ, *sch9*Δ and *isc1*Δ*sch9*Δ cells were grown to early stationary phase (day 1 in the CLS assay), stained with the dihydroethidium (DHE) for 10 min and analyzed by flow cytometry. Values are mean ± SD of at least three independent experiments. \*\*\*p\<0.001; \*\*p\<0.01.\
**(B)**Yeast cells were grown to the PDS phase and catalase activity was detected *in situ*after non-denaturing polyacrylamide gel electrophoresis, using the H~2~O~2~/peroxidase system, as described in *Materials and Methods*. A representative experiment out of three is shown.\
**(C)**BY4741, *isc1*Δ*, tor1*Δ and *isc1*Δ*tor1*Δ cells were double stained with DiOC~6~(3) and PI (propidium iodide) and analyzed by flow cytometry, as described in *Materials and Methods*. Representative histograms are shown.](mic-01-021-g05){#Fig5}

Increased ROS levels have been associated with homeostatic imbalance partially dictated by impaired cellular antioxidant defences. Hence, we hypothesized that the improvement of the mitochondrial function and dynamics in *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ cells may contribute to upregulate antioxidant defence mechanisms and decrease ROS levels during the aging process. It was previously shown that *isc1*Δ cells fail to induce *CTA1*gene expression in the PDS phase [@B65] and display a low activity of Cta1p [@B17], the catalase A form present in mitochondria and peroxisomes. Moreover, *CTA1*overexpression partially suppresses *isc1*Δ phenotypes [@B17]. Our results show that Cta1p activity was partially restored in *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ cells (Fig. 5B). In *sch9*Δ and *isc1*Δ*sch9*Δ cells, Ctt1p (cytosolic catalase) activity was not detected, which is consistent with the fact that the Sch9p kinase is directly or indirectly involved in the transcriptional control of *CTT1*expression in yeast [@B66]. The analysis of superoxide dismutase activity did not reveal changes in Sod1p (cytosolic form) or Sod2p (mitochondrial form) activity upon the deletion of *TOR1* or *SCH9* in *isc1*Δ cells (data not shown).

To evaluate if the decrease in ROS production and enhancement of antioxidant defenses (Cta1p) contribute to decrease apoptotic cell death in *isc1*Δ*tor1*Δ mutants, early stationary phase cells were labeled with DiOC~6~(3)/propidium iodide (PI). The analysis of yeast cells by flow cytometry allows the definition of four distinct populations: healthy cells (DiOC~6~(3)-positive/PI-negative), early apoptosis (DiOC~6~(3)-negative/PI-negative), late apoptosis (DiOC~6~(3)-positive/PI-positive) and necrosis (DiOC~6~(3)-negative/PI-positive). The results (Fig. 5C) clearly show that the large majority of parental and *tor1*Δ cells remained healthy whereas 62% of the *isc1*Δ cell population was already undergoing early (15%) or late (47%) apoptosis. In the *isc1*Δ*tor1*Δ double mutant, however, a significant decrease of apoptotic markers was observed, particularly at late stages where a reduction of approximately 50% (from 47% to 24%) was detected.

*SCH9* deletion but not reduced TORC1 signaling in *isc1*Δ cells attenuates Hog1p activation
--------------------------------------------------------------------------------------------

The hyperactivation of the HOG signaling pathway was previously implicated in the premature aging and mitochondrial dysfunction exhibited by Isc1p-deficient cells [@B18].

Thus, we hypothesized that the suppression of *isc1*Δ phenotypes by *TOR1* and *SCH9*deletion could be associated with the modulation of the HOG pathway. To address this question, Hog1p phosphorylation was monitored by Western blotting using an anti-phospho-p38 antibody that recognizes dually phosphorylated Hog1p, the active form of this kinase [@B67][@B68]. As illustrated in Fig. 6A, Hog1p phosphorylation was increased in *isc1*Δ cells when compared to parental cells. In contrast, phosphorylated Hog1p could not be detected in *tor1*Δ cells. Notably, Hog1p phosphorylation levels in *isc1*Δ*tor1*Δ cells were even higher to those detected in *isc1*Δ cells, suggesting a functional interplay between the HOG and TORC1 signaling pathways in *isc1*Δ cells.

![FIGURE 6: The deletion of *TOR1* increases Hog1p phosphorylation without affecting its cytosolic localization whereas *SCH9* disruption diminishes Hog1p phosphorylation in *isc1*Δ cells.\
**(A)**Hog1p activation was monitored in BY4741, *isc1*Δ*, tor1*Δ and *isc1*Δ*tor1*Δ cells by immunoblotting, using anti-phospho-p38 antibody (top panel) that detects the phosphorylated form of Hog1p, or anti-Pgk1p (loading control) as primary antibodies. A representative blot out of three is shown.\
**(B)***S. cerevisiae*BY4741, *isc1*Δ*, tor1*Δ and *isc1*Δ*tor1*Δ cells expressing the consensus Rlm1p binding sequences fused to a *LacZ* reporter (2xRLM1 - *LacZ*), were grown to the exponential phase and the β-galactosidase activity was measured as described in *Materials and Methods*. Values are mean ± SD of at least three independent experiments. \*\*\*\*p\<0.0001; \*\*\*p\<0.001; \*p\<0.05.\
**(C)** Hog1p activation was monitored in BY4741, *isc1*Δ*, sit4*Δ and *isc1*Δ*sit4*Δ cells by immunoblotting, as described in A. A representative blot out of three is shown.\
**(D)**Hog1p activation was monitored in BY4741, *isc1*Δ, *sch9*Δ and *isc1*Δ*sch9*Δ cells by immunoblotting, as described in A. BY4741 and *sch9*Δ cells were grown to the exponential phase and treated with either 10 μM C2-ceramide or DMSO (vehicle) for 1 h. A representative blot out of three is shown.](mic-01-021-g06){#Fig6}

It was previously shown that Hog1p activation leads to its import into the nucleus where it phosphorylates the Msn2p/Msn4p, Hot1p, Sko1p and Smp1p transcription factors to promote adaptation to stress conditions [@B69][@B70][@B71][@B72][@B73][@B74][@B75][@B76]. Thus, we have also monitored Hog1p cell localization by fluorescence microscopy in cells expressing Hog1p-GFP (Supplementary Fig. S4). Similarly to parental cells, Hog1p was present in the cytoplasm of *isc1*Δ, *tor1*Δ and *isc1*Δ*tor1*Δ mutants, implying that TORC1 may not regulate Hog1p localization. We have also evaluated the activation of the Cell Wall Integrity (CWI) pathway, since we have previously reported a Hog1p-dependent activation of Slt2p, a MAPK of the CWI pathway in *isc1*Δ cells [@B18]. For this purpose, we monitored the activation of Rlm1p, a transcription factor regulated by Slt2p, by measuring β-galactosidase activity in cells expressing a LacZ reporter under the control of Rlm1p promoter. Consistent with the hyperactivation of Hog1p and induction of the Rlm1p-driven LacZ reporter, β-galactosidase activity was increased by 1.7- and 4.3-fold in *isc1*Δ and *isc1*Δ*tor1*Δ cells, respectively (Fig. 6B).

It was previously shown that the protein phosphatase Sit4p is negatively regulated by TORC1 signaling [@B44] but activated by ceramide [@B77]. Moreover, the deletion of *SIT4* suppresses *isc1*Δ phenotypes [@B17]. Notably, Hog1p phosphorylation increased in *sit4*( cells and it was exacerbated in *isc1*Δ*sit4*Δ cells (Fig. 6C), as observed in *isc1*Δ*tor1*Δ cells (Fig. 6A). This suggests that the phosphorylation of Hog1p is regulated by a Sit4p-dependent mechanism.

Remarkably, the deletion of *SCH9*decreased Hog1p phosphorylation in *isc1*Δ cells (Fig. 6D). It was previously reported that ceramide signaling increases Hog1p phosphorylation [@B18]. Thus, we tested if Sch9p regulates the HOG pathway in response to ceramide. As previously reported, C2-ceramide treatment increased Hog1p phosphorylation in parental cells (Fig. 6D). In contrast, the deletion of *SCH9*completely abolished Hog1p activation upon treatment with ceramide (Fig. 6D). These results suggest that Sch9p is acting upstream of Hog1p in response to ceramide signaling.

Overall, the results show that the deletion of *TOR1* or *SIT4* does not suppress *isc1*Δ phenotypes through the attenuation of Hog1p hyperactivation and Sch9p appears to regulate the activation of the HOG pathway in response to ceramide in Isc1p-deficient cells.

DISCUSSION
==========

The TORC1 pathway is a well-established nutrient response pathway that modulates aging and age-related diseases [@B23]. Here we provided evidence that TORC1 signaling is deregulated in cells lacking Isc1p, the yeast orthologue of mammalian neutral sphingomyelinase. Isc1p-deficient cells exhibit increased TORC1 activity, which is detrimental for this mutant. In fact, the deletion of *TOR1* alleviates the premature aging, oxidative stress sensitivity and mitochondrial dysfunctions of *isc1*Δ cells. However, *isc1*Δ*tor1*Δ cells exhibit lower resistance to oxidative stress, shortened CLS, slightly impaired mitochondrial function, and higher levels of ROS and apoptotic cell death markers compared to the *tor1*Δ mutant strain, suggesting that TORC1-independent mechanisms also contributes to *isc1*Δ phenotypes. In agreement, the overexpression of *ISC1* does not suppress the rapamycin hypersensitivity of *tor1*Δ mutants, suggesting that Isc1p is not acting downstream of TORC1 (Supplementary Fig. S5).

Several lines of evidence suggest an intricate interplay between sphingolipid metabolism and TOR signaling. Both TORC1 and TORC2 control the biosynthesis of sphingolipids through regulation of Orm1p and Orm2p, two evolutionarily conserved integral membrane proteins of the endoplasmic reticulum [@B78][@B79][@B80]. However, TORC1 and TORC2 signaling seems to function independently in the regulation of sphingolipid metabolism. TORC1 negatively controls the synthesis of complex sphingolipids from ceramide via inhibition of Orm1/2p phosphorylation in a process mediated by Npr1p [@B80]. TORC2 stimulates the *de novo* biosynthesis of sphingolipids via activation of Ypk1p, which then phosphorylates and inactivates Orm1/2p [@B81]. Since Orm1/2p bind to and inhibit serine palmitoyl-coenzyme A transferase (SPT) [@B82], which catalyzes the first step in sphingolipid biosynthesis [@B83], its inactivation by a Ypk1p-dependent phosphorylation alleviates SPT inhibition and increases sphingolipid production. In addition, TORC2 stimulates ceramide biosynthesis by an Ypk2p-dependent mechanism [@B30] and inhibits Isc1p activity via modulation of Slm1/2p [@B31][@B84].

Our data suggests a genetic interaction between *ISC1* and *TOR1*. A recent report suggests a link between ceramide generated by mammalian acid sphingomyelinase under amino acid deprivation conditions and mTOR inactivation by a PP1/PP2A-dependent mechanism [@B85]. Notably, yeast Isc1p appears to occupy a central position and may possibly act as a metabolic hub (together with ceramide synthase) in the TOR pathway to regulate ceramide dynamics, since Isc1p is functionally linked with both TORC1 and TORC2 branches. In particular, the modulation of complex sphingolipids turnover by coupling TORC1-regulated biosynthesis with Isc1p-driven hydrolysis may be important to control ceramide flux in yeast.

The molecular mechanism by which TORC1 is activated in *isc1*Δ cells remains to be elucidated. Nevertheless, the activation of TORC1 in Isc1p-deficient cells may be part of a homeostatic response that aims to decrease the synthesis of complex sphingolipids, since *isc1*Δ cells accumulate inositolphosphorylceramide (IPC) and mannosyldiinositolphosphorylceramide (M(IP)~2~C) [@B31][@B86] and TORC1 negatively controls their biosynthesis [@B80]. However, TORC1 activation impairs mitochondrial function and oxidative stress resistance in *isc1*Δ cells, and *TOR1* deletion suppresses *isc1*Δ phenotypes. Such features are in agreement with previous studies showing that *TOR1* deletion regulates yeast CLS by a cell-intrinsic mechanism [@B32][@B33]. Reduced TORC1 signaling increases mitochondrial coupling during active growth in yeast cells, eliciting an adaptive response that preconditions yeast cells to better survive in the stationary phase and promotes longevity [@B33]. Furthermore, *TOR1* disruption leads to an increased translation of mtDNA-encoded subunits of the oxidative phosphorylation system [@B32], which is consistent with the higher oxygen consumption and COX activity observed in this study. In addition, it improves oxidative stress resistance in the stationary phase [@B50].

In the present study, we demonstrate that TORC1-driven Sch9p C-terminal phosphorylation is increased in *isc1*Δ cells and our results are consistent with TORC1 acting through Sch9p-associated mechanisms since the disruption of both *TOR1*and *SCH9*abolishes *isc1*Δ phenotypes. Importantly, Isc1p-deficient cells presented reduced autophagic flux, both upon treatment with rapamycin and during cell aging, which is consistent with the activation of the TORC1-Sch9p pathway. In agreement, *TOR1* and *SCH9* disruption reestablished the functional integrity of autophagy in *isc1*Δ cells and this is correlated with the restoration of mitochondrial function in the double mutants, ultimately abolishing the H~2~O~2~ hypersensitivity and premature aging exhibited by this mutant strain.

It was previously demonstrated that the accumulation of very long chain ceramide species (dihydro-C~26~-ceramide and phyto-C~26~-ceramide species) and ceramide-activation of the protein phosphatase Sit4p are also implicated in *isc1*Δ phenotypes [@B17]. Since TORC1 negatively regulates Sit4p by promoting its association with the inhibitor Tap42p [@B44] and both *TOR1* and *SIT4* deletions suppress *isc1*Δ phenotypes, we propose that Sit4p may act in parallel to TORC1 signaling, by directly sensing ceramide signals (Fig. 7).

![FIGURE 7: Sit4p and Sch9p integrate nutrient and stress signaling from TORC1 with ceramide signals to regulate mitochondrial function and CLS in yeast.\
Cells lacking Isc1p present increased TORC1-Sch9p activity, ultimately leading to mitochondrial dysfunction, decreased oxidative stress resistance and shortened CLS. Apart from sensing signals from TORC1, the ceramide activated protein phosphatase Sit4p and the AGC protein kinase Sch9p also integrate ceramide signaling derived from Isc1p to regulate mitochondrial function, oxidative stress resistance and chronological lifespan in yeast.](mic-01-021-g07){#Fig7}

Several pieces of evidence suggest a functional link between sphingolipids, TOR signaling and the HOG pathway. The constitutive activation of Hog1p is deleterious for *isc1*Δ cells since the deletion of *HOG1* attenuates the shortened CLS, hydrogen peroxide sensitivity and mitochondrial dysfunctions of this mutant strain [@B18]. The HOG pathway is activated upon treatment of yeast cells with myriocin, an inhibitor of the *de novo* sphingolipid biosynthesis, and in cells with impaired synthesis of IPC [@B87]. In addition, reduced TOR signaling lowers the basal activity of Hog1p in *Candida albicans* through the Hog1p tyrosine phosphatases Ptp2 and Ptp3 [@B88] and our results show a decrease of Hog1p basal phosphorylation in the *tor1*Δ mutant. In this study, we demonstrate that *TOR1* deletion does not suppress Hog1p hyperactivation or alter Hog1p localization in *isc1*Δ cells. However, our results support a more intricate interplay between the two signaling pathways in *isc1*Δ cells. Indeed, Hog1p phosphorylation was even increased in *isc1*Δ*tor1*Δ cells in comparison to *isc1*Δ cells and remarkably a similar feature was also observed for both *sit*4Δ and *isc1*Δ*sit*4Δ cells, which present extended lifespan when compared to *isc1*Δ or even to parental cells [@B17]. We propose that the deletion of *TOR1* or *SIT4* either suppresses putative deleterious effects of Hog1p hyperactivation on mitochondrial function and CLS or modulates the regulatory role of Hog1p to determine cell fate in Isc1p-deficient cells. In fact, the activation of yeast Hog1p or its mammalian orthologue, p38 MAPK, has been implicated in both cell survival and cell death. For example, *HOG1* deletion decreases osmotic and oxidative stress resistance and shortens CLS in yeast [@B89][@B90]. However, the expression of constitutively active Hog1p mutant kinases or constitutive activation of the HOG pathway is lethal [@B91][@B92][@B93], and hyperactivation of Hog1p is detrimental under heat stress conditions [@B94]. In mammalian cells, p38 MAPK is activated during the onset of senescence [@B95][@B96], its inhibition moderately delays replicative senescence [@B97] and its activation promotes apoptosis [@B98][@B99].

Remarkably, we provide significant evidence that the activation of the *HOG* pathway is modulated by ceramide signaling by Sch9p-dependent mechanisms, ultimately contributing to *isc1*Δ phenotypes. Indeed, C2-ceramide-induced Hog1p phosphorylation [@B18] was suppressed by the disruption of *SCH9*. In addition, Hog1p phosphorylation decreased upon deletion of *SCH9* in Isc1p-deficient cells. Overall, the results suggest that both proteins act in the same pathway since *SCH9* (this study) and *HOG1* [@B18] deletions suppressed *isc1*Δ phenotypes. Therefore, our results points out to a model in which Sch9p integrates nutrient and stress signals from TORC1 with ceramide signaling, the latter contributing to the modulation of the Hog1p phosphorylation. Interestingly, this appears to be ceramide-specific since treatment with phytosphingosine had no effect on Hog1p phosphorylation (data not shown). It is known that Sch9p possesses a C2-domain, which is known to bind to several substrates, namely Ca^2+^, phospholipids, inositol polyphosphates, and intracellular proteins [@B100]. Whether ceramide acts by binding directly to the C2-domain remains to be established.

In summary, our data implicate TORC1-Sch9p activation in the mitochondrial dysfunction, premature aging, oxidative stress sensitivity and impaired autophagy exhibited by *isc1*Δ cells. However, Isc1p and TORC1 also seem to act through independent pathways, as *isc1*Δ*tor1*Δ phenotypes are intermediate to those displayed by *isc1*Δ and *tor1*Δ cells.

The lifespan extension in *isc1*Δ cells imparted by reduced TORC1 signaling is not associated with the attenuation of Hog1p hyperphosphorylation. Our results suggest that complex signaling interconnections involving TORC1 and its downstream effectors Sch9p and Sit4p govern the redox homeostasis and lifespan of *isc1*Δ cells and support a model in which both proteins act as physiological core centers integrating nutrient and stress signal from TORC1 and ceramide signaling derived from Isc1p to regulate mitochondrial function and CLS in yeast (Fig. 7).

MATERIALS AND METHODS
=====================

Yeast cells and growth conditions
---------------------------------

*S. cerevisiae* BY4741 was the parental strain of all haploid derivatives used in this study (Table 1). Yeast cells were grown aerobically at 26°C in a gyratory shaker (at 140 r.p.m.), with a ratio of flask volume/ medium volume of 5:1. The growth media used were YPD \[1% (w/v) yeast extract, 2% (w/v) bactopeptone, 2% (w/v) glucose\], YPGlycerol \[1% (w/v) yeast extract, 2% (w/v) bactopeptone, 4% (v/v) glycerol\] or synthetic complete (SC) drop-out medium containing 2% (w/v) glucose, 0.67% yeast nitrogen base without amino acids and supplemented with appropriate amino acids (80 mg histidine L^-1^, 400 mg leucine L^-1^, 80 mg tryptophan L^-1^ and 80 mg uracil L^-1^). The *tor1*Δ cells were obtained by replacing *TOR1* with a *tor1*::*KanMX4* deletion cassette amplified by polymerase chain reaction (PCR) using the corresponding strain available from EUROSCARF (Germany) and the following primers: Fw (GA GAATCATTACCGGCGAAA) and Rv (ACGAACACGTTTTGGTG ATG). For *ISC1*disruption in *tor1*Δ and*sch9*Δ::*KanMX4*cells, a deletion fragment containing *LEU2*and the flanking regions of *ISC1*was amplified by PCR using pRS315 and the following primers: Fw (ATTTGCGCTTTCCGTAAAAAGGGAAAAAAAGCA GATATTTAAGCAAGGATTTTCT) and Rv (TCAGTAATTTTTTTACA TATGCTAAAGAAAATCGATAATACCGCATATCGACCCTCGAGGA G). Cells were transformed by electroporation. The *tor1*Δ cells were selected in YPD medium containing geneticin (0.4 mg.mL^-1^) whereas *isc1*Δ*tor1*Δ and *isc1*Δ*sch9*Δ cells were selected in minimal medium lacking leucine \[0.67% (w/v) yeast nitrogen base without amino acids, 2% (w/v) glucose supplemented with appropriate amino acids (40 mg histidine L^-1^, 40 mg uracil L^-1^ and 40 mg methionine L^-1^)\]. The correct insertion of all cassettes was confirmed by PCR.

###### 

*Saccharomyces cerevisiae* strains used in this study. Harboring plasmids are shown in square brackets.

  **Strain**       **Genotype**                                                                                                                                               **Source**
  ---------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  BY4741           Mata *his3*Δ*1, leu2*Δ*0, met15*Δ*0, ura3*Δ*0*\[pJU676, pYX222-mtDsRed, pRS416-*GFP-ATG8*, pRS416-*HOG1-GFP,*pLGΔ312-2xRLM1-*LacZ,*pYES2, pYES2-*ISC1*\]   EUROSCARF
  *isc1*Δ          BY4741 *isc1*Δ::*KanMX4*\[pJU676, pYX222-mtDsRed, pRS416-*GFP-ATG8*, pRS416-*HOG1-GFP,*pLGΔ312-2xRLM1-*LacZ*\]                                             EUROSCARF
  *tor1*Δ          BY4741 *tor1*Δ::*KanMX4* \[pYX222-mtDsRed, pRS416-*GFP-ATG8*, pRS416-*HOG1-GFP,*pLGΔ312-2xRLM1-*LacZ,*pYES2, pYES2-*ISC1*\]                                This study
  *isc1*Δ*tor1*Δ   BY4741 *isc1*Δ::*LEU2* *tor1*Δ::*KanMX4*\[pYX222-mtDsRed, pRS416-*GFP-ATG8*, pRS416-*HOG1-GFP,*pLGΔ312-2xRLM1-*LacZ*\]                                     This study
  *sch9*Δ          BY4741 *sch9*Δ::*KanMX4*\[pYX222-mtDsRed, pRS416-*GFP-ATG8*\]                                                                                              EUROSCARF
  *isc1*Δ*sch9*Δ   BY4741 *isc1*Δ::*LEU2* *sch9*Δ::*KanMX4*\[pYX222-mtDsRed, pRS416-*GFP-ATG8*\]                                                                              This study
  *sit4*Δ          BY4741 *sit4*Δ::*KanMX4*                                                                                                                                   EUROSCARF
  *isc1*Δ*sit4*Δ   BY4741 *isc1*Δ::*URA3* *sit4*Δ::*KanMX4*                                                                                                                   [@B17]

To evaluate TORC1-dependent C-terminal phosphorylation of Sch9p, BY4741 and *isc1*∆ cells were transformed by electroporation with pJU676 [@B45] and selected in minimal medium lacking uracil. For the analysis of mitochondrial morphology, yeast cells were transformed with a plasmid expressing mitochondrial DsRed (pYX222-mtDsRed) and selected in minimal medium lacking histidine. To evaluate autophagic flux, cells were transformed by electroporation with pRS416-GFP-*ATG8* [@B101] and selected in minimal medium lacking uracil. For Hog1p localization assays, yeast cells were transformed with pRS416-*HOG1*-GFP [@B102] and selected in minimal medium lacking uracil. To assess the activation of the CWI pathway by Rlm1p reporter transcriptional activity, yeast cells were transformed with pLG(312-2xRLM1-*LacZ* [@B103] and selected in minimal medium lacking uracil. For epistatic analysis, BY4741 and *tor1*Δ strains were transformed with pYES2 and pYES2-*ISC1* [@B16] and selected in minimal medium lacking uracil.

Stress resistance and chronological lifespan
--------------------------------------------

For H~2~O~2~ resistance assay, cells were grown to the exponential phase (OD~600~ = 0.6) or early stationary phase (48h after exponential phase) and exposed to 1.5 mM or 300 mM H~2~O~2~ (Merck) for 60 and 30 min, respectively. The CLS assay was performed as described [@B104]. For both assays, cell viability was determined by standard dilution plate counts on YPD medium containing 1.5 % (w/v) agar and expressed as the percentage of the colony-forming units after growth at 26°C for 3 days (time *T* vs. T~0~(when viability was considered 100%) for the CLS assay; treated vs. untreated cells for H~2~O~2~ resistance). Values are mean ± SD of at least three independent experiments.

Enzymatic activities and oxygen consumption
-------------------------------------------

For enzyme activities, yeast cells were harvested by centrifugation for 5 min at 4,000 r.p.m. (4°C). Cells were then resuspended in 50 mM potassium phosphate buffer (pH 7.0) containing protease inhibitors (Complete, Mini, EDTA-free Protease Cocktail Inhibitor Tablets; Boehringer Mannhein) and phosphatase inhibitors (50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM sodium orthovanadate). Total protein extracts were obtained by mechanical disruption through vigorous shaking of the cell suspension in the presence of glass beads for 5 min. Short pulses of 1 min were applied followed by 1 min incubation on ice. Cell debris was removed by centrifugation at 13,000 r.p.m. for 15 min and protein content was determined by the method of Lowry, using bovine serum albumin as a standard. Catalase activity was analyzed *in situ,*in the presence of 3,3\'-diaminobenzidine tetrahydrochloride, using the H~2~O~2~/peroxidase system [@B105]. Cytochrome *c* oxidase (COX) activity was determined by measuring cytochrome *c*oxidation [@B106]. β-galactosidase activity determination was performed as previously reported [@B18]. Oxygen consumption rate was measured for 3 x 10^8^ cells in PBS buffer (pH 7.4), using an oxygen electrode (Oxygraph, Hansatech). Data was analyzed using the Oxyg32 V2.25 software.

Mitochondrial membrane potential, ROS levels and cell death
-----------------------------------------------------------

The mitochondrial membrane potential was measured using the potential-sensitive dye DiOC~6~(3). Briefly, 2x10^6^ cells were resuspended in sample buffer \[10 mM 2-(N-morpholino) ethanesulfonic acid, 0.1 mM MgCl2 and 2% (w/v) glucose, pH 6.0\"\>10 mM 2-(N-morpholino) ethanesulfonic acid, 0.1 mM MgCl2 and 2% (w/v) glucose, pH 6.0\]. DiOC~6~(3) (Molecular Probes) was added to a final concentration of 1 nM. The cell suspension was then incubated for 30 min at 26°C, collected by centrifugation and washed twice with PBS. Fluorescence was measured on the FL-1 channel of a Becton Dickinson FACS Calibur Analytic Flow cytometer with excitation and emission settings of 488 nm and 515-545 nm, respectively, without compensation. For the quantification of ROS levels, 5x10^6^ cells were resuspended in PBS and the superoxide anion sensitive probe dihydroethidium (DHE, Molecular Probes) was added to a final concentration of 5 μM. Cells were incubated for 10 min at 26°C, pelleted by centrifugation, washed twice with PBS and analyzed by flow cytometry with excitation and emission settings of 488 nm and ≥670 nm (FL-3 channel), without compensation.

For the characterization of the cell death process, cells were dually stained with DiOC~6~(3) (1 nM) and propidium iodide (PI, 2μg mL^-1^, Molecular Probes) to evaluate mitochondrial membrane polarization and the plasma membrane integrity, respectively. Cells were incubated for 30 min at 26°C and harvested as previously described. After suitable compensation, fluorescence was measured by flow cytometry at different wavelengths: excitation/emission at 488/525 nm for DiOC~6~(3) (FL-1 channel), and at 536/600 nm for PI (FL-3 channel). Data treatment was performed using the FlowJo software (Tree Star).

Western Blot analysis
---------------------

To evaluate the TORC1-dependent C-terminal phosphorylation of Sch9p, cells transformed with pJU676 (expressing *SCH9-5HA*) were grown in SC-medium lacking uracil to the exponential phase. NTCB-chemical fragmentation analysis was done as described [@B45]. Proteins were then analyzed by SDS-PAGE using 10% polyacrylamide gels and blotted onto a nitrocellulose membrane (GE Healthcare, Buckinghamshire, United Kingdom). Immunodetection was performed using rabbit anti-HA (Sigma-Aldrich) at a 1:1,000 dilution as primary antibody, goat anti-rabbit IgG-peroxidase (Sigma-Aldrich) at a 1:5,000 dilution as secondary antibody, and the Lumigen HRP chemiluminescent substrate (GE Healthcare, RPN2109, Buckinghamshire, United Kingdom).

To monitor Hog1p phosphorylation, yeast cells were grown to the exponential phase and protein extracts (50 μg) were separated by SDS-PAGE and blotted onto a nitrocellulose membrane (GE Healthcare, Buckinghamshire, United Kingdom). The membrane was incubated with the primary antibodies rabbit anti-phospho-p38 MAPK (Cell Signaling Technology, Denver, USA) at a 1:500 dilution or mouse anti-Pgk1p (Invitrogen, Carlsbad, USA) at a 1:30,000 dilution. Subsequently, the membrane was incubated with the secondary antibodies, anti-rabbit IgG-peroxidase (Sigma-Aldrich) at a 1:5,000 dilution, or anti-mouse IgG-peroxidase (Molecular Probes) at a 1:3,000 dilution. Immunodetection was performed as described above.

The evaluation of LCBs mediated Phk1/2-dependent phosphorylation of Sch9p was performed as described [@B14]. To assess alterations in autophagic flux, cells were grown to the exponential phase in SC-medium and treated with either rapamycin (200 ng mL^-1^, (Sigma-Aldrich) or DMSO (vehicle, Sigma-Aldrich) for 3 hours. For CLS assay, cells were grown to the PDS phase, washed twice with water and then maintained in water overtime. Total protein extracts (30 μg) were analyzed in similar conditions as previously described. The membrane was incubated with the primary antibodies mouse anti-GFP (Roche, Basel, Switzerland) at a 1:3,000 dilution or mouse anti-Pgk1p (Invitrogen, Carlsbad, USA) at a 1:30,000 dilution. Subsequently, the membrane was incubated with the secondary antibody anti-mouse IgG-peroxidase (Molecular Probes) at a 1:3,000 dilution. Immunodetection was done as described.

Fluorescence microscopy
-----------------------

For mitochondrial morphology analysis, cells transformed with pYX222-mtDsRed were grown in SC-medium lacking histidine to the exponential or PDS phase. To assess Hog1p cell localization, cells expressing Hog1p-GFP were grown in SC-medium lacking uracil to the exponential phase. Live cells were observed by fluorescence microscopy (AxioImager Z1, Carl Zeiss). Data image stacks were deconvolved by QMLE algorithm of Huygens Professional v3.0.2p1 (Scientific Volume Imaging B.V.). Maximum intensity projection was used to output final images using ImageJ 1.45v software.

Statistical analysis
--------------------

Data are expressed as mean values ± SD of at least three independent experiments. Values were compared by Student's *t-test.*The 0.05 probability level was chosen as the point of statistical significance throughout. Statistical analyses were carried out using GraphPad Prism Software v5.01 (GraphPad Software).

SUPPLEMENTAL MATERIAL
=====================

###### 

Click here for supplemental data file.

All supplemental data for this article are also available online at <http://microbialcell.com/researcharticles/reduced-torc1-signaling-abolishes-mitochondrial-dysfunctions-shortened-chronological-lifespan-isc1p-deficient-cells/>.
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